Clinical Trials Directory

Trials / Sponsors / Korean Cancer Study Group

Korean Cancer Study Group

Academic / Other · 9 registered clinical trials.

StatusTrialPhaseStarted
WithdrawnA Phase lb/ll, Open Label, Single Arm Study With Olinvacimab and Capecitabine in mCRC Patients (OLCAP)
Colorectal Cancer Metastatic
Phase 1 / Phase 22022-01-01
UnknownGut Microbiome and Its Immune Modulation in Locally Advanced Rectal Cancer
Locally Advanced Rectal Cancer
N/A2021-12-15
UnknownAlpelisib and Capecitabine in Patients With PIK3CA Mutant mCRC Patients
Metastatic Colorectal Cancer, PIK3CA Gene Mutation
Phase 1 / Phase 22021-02-28
UnknownPhase II Study of Herzuma® Plus Gedatolisib in Patients With HER-2 Positive Metastatic Breast Cancer
HER2-positive Breast Cancer, Metastatic Breast Cancer
Phase 22019-12-03
UnknownA Phase II Study of Nivolumab in Patients With Genetic Alterations in DNA Damage Repair and Response Who Progr
DDR Gene Mutation, Metastatic Solid Tumor
Phase 22019-06-14
CompletedDovitinib(TKI258) in Patients With Castration-resistant Prostate Cancer
Hormone Refractory Prostate Cancer
Phase 22012-11-01
TerminatedPaclitaxel and Cisplatin for Thymic Neoplasm
Thymoma, Thymic Carcinoma
Phase 22008-09-01
UnknownS-1 and Irinotecan Combination Chemotherapy for Advanced Gastric Cancer
Gastric Cancer
Phase 22005-09-01
UnknownEfficacy Study of Paclitaxel Versus Irinotecan in Patients With Recurrent or Metastatic Gastric Cancer Who Pro
Gastric Cancer
Phase 3—